Announced Tue, 30 Jun · 16:14 IST
Trading Window closed from July 1 ahead of Q1 results
Compliance View source PDF
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.3%1-day move
₹931.80
prior close
₹939.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.1-0.2-0.4+0.3+0.2-0.1+5.5+3.7+5.5+0.0———
Up moveDown movePending
AI summary
Natco Pharma has closed its trading window for dealing in company securities starting July 1, 2026. The closure applies to directors, designated persons, their immediate relatives and other connected persons under SEBI insider trading rules. The window will reopen 48 hours after the company declares its unaudited financial results for the quarter ending June 30, 2026. The board meeting date to announce these results will be communicated later.
Likely market impact
Routine compliance notice. Signals upcoming Q1 FY27 results announcement in the coming weeks.